Related Experiment Video
Updated: Oct 30, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
The Effect of a Lifestyle Intervention on Type 2 Diabetes Pathophysiology and Remission: The Stevenshof Pilot Study
Iris M de Hoogh1, Johanneke E Oosterman1, Wilma Otten2
1Research Group Microbiology & Systems Biology, TNO, Netherlands Organization for Applied Scientific Research, 3700 AJ Zeist, The Netherlands.
Abstract:
Although lifestyle interventions can lead to diabetes remission, it is unclear to what extent type 2 diabetes (T2D) remission alters or improves the underlying pathophysiology of the disease. Here, we assess the effects of a lifestyle intervention on T2D reversal or remission and the effects on the underlying pathology. In a Dutch primary care setting, 15 adults with an average T2D duration of 13.4 years who were (pharmacologically) treated for T2D received a diabetes subtyping ("diabetyping") lifestyle intervention (DLI) for six months, aiming for T2D remission. T2D subtype was determined based on an OGTT. Insulin and sulphonylurea (SU) derivative treatment could be terminated for all participants. Body weight, waist/hip ratio, triglyceride levels, HbA1c, fasting, and 2h glucose were significantly improved after three and six months of intervention. Remission and reversal were achieved in two and three participants, respectively. Indices of insulin resistance and beta cell capacity improved, but never reached healthy values, resulting in unchanged T2D subtypes. Our study implies that achieving diabetes remission in individuals with a longer T2D duration is possible, but underlying pathology is only minimally affected, possibly due to an impaired beta cell function. Thus, even when T2D remission is achieved, patients need to continue adhering to lifestyle therapy.
Insights
Lifestyle interventions can help achieve type 2 diabetes (T2D) remission, even in long-standing cases. However, the underlying disease pathology is only minimally improved, highlighting the need for continued lifestyle adherence.
Area of Science:
- Metabolic diseases
- Endocrinology
- Primary care research
Background:
- Lifestyle interventions show promise for type 2 diabetes (T2D) remission.
- The impact of T2D remission on underlying disease pathophysiology remains unclear.
- Understanding these effects is crucial for long-term diabetes management.
Purpose of the Study:
- To assess the effects of a lifestyle intervention on T2D remission and reversal.
- To evaluate the impact of remission on the underlying pathophysiology of T2D.
- To determine if T2D subtypes change with remission.
Main Methods:
- A six-month "diabetyping" lifestyle intervention (DLI) was applied to 15 adults with T2D in Dutch primary care.
- Participants underwent diabetes subtyping based on an oral glucose tolerance test (OGTT).
- Medication (insulin, sulfonylurea derivatives) was discontinued; various metabolic markers were monitored.
Main Results:
- Significant improvements in body weight, waist/hip ratio, triglycerides, HbA1c, fasting, and 2h glucose were observed.
- T2D remission and reversal were achieved in 2 and 3 participants, respectively.
- Insulin resistance and beta cell capacity improved but did not normalize, and T2D subtypes remained unchanged.
Conclusions:
- Diabetes remission is achievable in individuals with longer T2D duration through lifestyle interventions.
- Underlying T2D pathology is minimally affected, potentially due to persistent beta cell dysfunction.
- Continued adherence to lifestyle therapy is essential even after achieving diabetes remission.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Atherosclerosis III: Management
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

